LONDON — A coworking space surrounded by the crush of traffic around King’s Cross station is perhaps not the most glamorous digs. But as the site of Flagship Pioneering’s U.K. outpost, it fits.
Not far are University College London, the Wellcome Trust, and the Francis Crick Institute. Novo Nordisk and Merck have major hubs nearby, as do Meta and Google.
Flagship, the high-profile venture firm, opened its U.K. office last year, and also unveiled Quotient Therapeutics, a biotech split between Cambridge, Mass., and Cambridge, England. But it was only last month that Junaid Bajwa, the head of Flagship’s U.K. efforts, officially started.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in